Brookline Capital Markets analyst Kumaraguru Raja initiates coverage on Edesa Biotech Inc. (NASDAQ: EDSA) with a Buy rating and a ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments New Coverage